miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....